NCT00809250
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Leukemia, Myelomonocytic, Chronic
Explore clinical trials studying Leukemia, Myelomonocytic, Chronic. Study availability and eligibility vary by location and protocol.
416 public trials
60 recruiting studies
Leukemia, Myelomonocytic, Chronic trial results
NCT00309842
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +66 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
- Locations
-
- Georgia Health Sciences University Dept. of MCG Augusta, Georgia, United States
- Goshen Center for Cancer Care IU Cancer Center Indianapolis, Indiana, United States
- University of Kansas Hospital and Medical Center SC - Univ KS Kansas City, Kansas, United States
- Dana Farber Cancer Institute Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States
Completed
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
NCT00006083
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +94 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
NCT00079222
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
NCT00274820
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloproliferative Disorders, +16 more
- Locations
-
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00750009
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +106 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
Completed
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
NCT01241500
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
- Locations
-
- Virginia G. Piper Cancer Center Scottsdale, Arizona, United States
- University of California San Diego Moores Cancer Center La Jolla, California, United States
- Stanford Cancer Center Stanford, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
NCT01928537
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
- Locations
-
- Stanford University Cancer Center Stanford, California, United States
- Rush University Medical Center Chicago, Illinois, United States
- University of Chicago Medicine Chicago, Illinois, United States
- University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States
NCT02472691
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
- Locations
-
- University Hospital Duesseldorf, Dept. of Hematology, Oncology and Clinical Immunology Düsseldorf, North Rhine-Westphalia, Germany